Harmony Biosciences Holdings HRMY
NASDAQ HRMY
$39.64 +0.07 (+0.18%)
At close: Oct 2, 2026 · 4:00 PM EDT

Harmony Biosciences Holdings (HRMY) Cost of Revenue (2020 - 2026)

Updated

Harmony Biosciences Holdings (HRMY) reported Cost of Revenue of $63.2 million for Q2 2026, up 65.6% from $38.15 million a year earlier and up 42.0% from the prior quarter.

Analysis

Harmony Biosciences Holdings (HRMY) Cost of Revenue (2020 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Harmony Biosciences Holdings' Cost of Revenue came in at $235.91 million, up 41.0% year-over-year; for FY2025, it was $198.34 million, up 26.5% from FY2024.

  • Cost of Revenue has increased for five consecutive years, with a five-year compound annual growth rate of 48.2% (FY2020 to FY2025).
  • By year, Cost of Revenue came in at $156.82 million in FY2024 (+29.3%), $121.24 million in FY2023 (+45.2%), $83.48 million in FY2022 (+50.4%) and $55.52 million in FY2021 (+100.2%).
  • Five-year quarterly Cost of Revenue spans a low of $14.6 million in Q3 2021 and a high of $68.55 million in Q4 2025.
  • Year over year, Cost of Revenue has now increased in each of the last 22 quarters, with growth averaging 33.0% over the last eight quarters.
  • Across the past five years, year-over-year growth in Cost of Revenue ran from 16.4% in Q1 2025 to 85.1% in Q3 2021.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $44.51 million (Q1 2026), $68.55 million (Q4 2025) and $59.65 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 8.05 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.29 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.52 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.58 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.09 Bn
10 Harmony Biosciences Holdings 2.30 Bn -452.73 Mn 198.08 Mn 63.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 63.20 Mn
Mar 31, 2026 44.51 Mn
Dec 31, 2025 68.55 Mn
Sep 30, 2025 59.65 Mn
Jun 30, 2025 38.15 Mn
Mar 31, 2025 31.99 Mn
Dec 31, 2024 54.41 Mn
Sep 30, 2024 42.78 Mn
Jun 30, 2024 32.14 Mn
Mar 31, 2024 27.48 Mn
Dec 31, 2023 43.15 Mn
Sep 30, 2023 32.30 Mn
Jun 30, 2023 25.01 Mn
Mar 31, 2023 20.78 Mn
Dec 31, 2022 26.89 Mn
Sep 30, 2022 22.96 Mn
Jun 30, 2022 18.92 Mn
Mar 31, 2022 14.72 Mn
Dec 31, 2021 17.82 Mn
Sep 30, 2021 14.60 Mn
API Access

Harmony Biosciences Holdings Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=HRMY&period=max&api_key=YOUR_API_KEY